-
Catalog
C001852
-
Alternative name
Insulin-like growth factor-binding protein 7 CLIA KIT; IGFBP-rP1 CLIA KIT; MAC25 protein CLIA KIT; PGI2-stimulating factor CLIA KIT; Prostacyclin-stimulating factor CLIA KIT; Tumor-derived adhesion factor CLIA KIT; TAFIGFBP7 CLIA KIT; MAC25 CLIA KIT; PSF CLIA KIT; IBP-7 CLIA KIT; IGF-binding protein 7 CLIA KIT; IGFBP-7 CLIA KIT; TAF CLIA KIT
-
GeneIGFBP7
-
Species ReactivityHuman
-
SpecificityThis assay has high sensitivity and excellent specificity for detection of Insulin Like Growth Factor Binding Protein 7 (IGFBP7).
No significant cross-reactivity or interference between Insulin Like Growth Factor Binding Protein 7 (IGFBP7) and analogues was observed.
-
SamplesSerum, plasma and other biological fluids
-
Detection Range0.82-600ng/mL
-
SensitivityThe minimum detectable dose of this kit is typically less than 0.31ng/mL.
-
PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Insulin Like Growth Factor Binding Protein 7 (IGFBP7) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Insulin Like Growth Factor Binding Protein 7 (IGFBP7) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
-
Product Description specificalPrinciple of the Assay: The microtiter plate provided in this kit has been pre-coated with an antigen. Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated secondary antibody. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Insulin Like Growth Factor Binding Protein 7 (IGFBP7) level in the sample or standard.
-